DeGirum Announces Partnership with Axelera AI
Axelera AI Metis Edge AI Accelerators Powered by DeGirum Software
Comprehensive Platform Enables Customers to Rapidly Create and Deploy Solutions with DeGirum Face Recognition and PySDK
Key Benefits
- Proven Edge AI Solution: Deploy computer vision, generative AI, and inferencing applications seamlessly, free from proprietary development restrictions.
- Scalability: Applications scale effortlessly with additional hardware, requiring no code changes.
- No Support Costs: Axelera customers receive one year of premium technical support from DeGirum at no cost.
- Hardware Performance Testing: Users can remotely benchmark models on various hardware configurations.
"Our mission is to provide industry-leading performance in an easy-to-use platform that's accessible to everyone. Partnering with DeGirum provides our developers another great option for building their inference solutions and deploying them at scale," said
"The Axelera AI and DeGirum partnership expands our reach, integrating our application packages like DeGirum Face Recognition and PySDK with Axelera AI's advanced MetisEdge AI Processors," said
About DeGirum
https://www.degirum.com/company
About Axelera AI
https://axelera.ai/our-story
Contacts:
[email protected]
Bill Eichen
VP Business Development
[email protected]
650-868-4999
View original content to download multimedia:https://www.prnewswire.com/news-releases/degirum-announces-partnership-with-axelera-ai-302713144.html
SOURCE DeGirum Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cardinal Health Board of Directors Approves Quarterly Dividend
- n6 expands global distribution footprint, bringing iconPCR™ and AutoNorm to more scientists across Europe, the Middle East, and Africa
- As GLP-1 Medications Reshape America, Prime Cuts Beef Jerky Identifies a New Consumer Movement Driving the Rise of Gas Station Gourmet
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share